Standout Papers

Everolimus for Advanced Pancreatic Neuroendocrine Tumors 2006 2026 2012 2019 2.0k
  1. Everolimus for Advanced Pancreatic Neuroendocrine Tumors (2011)
    James C. Yao, Manisha H. Shah et al. New England Journal of Medicine
  2. Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis (2006)
    Ludwig Kappos, Jack P. Antel et al. New England Journal of Medicine

Citation Impact

22 from Science/Nature 54 standout
Sub-graph 1 of 19

Citing Papers

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
2022 Standout
Immune checkpoint inhibitors in melanoma
2021 Standout
13 intermediate papers

Works of T Haas being referenced

LBA43 Spartalizumab plus dabrafenib and trametinib (Sparta-DabTram) in patients (pts) with previously untreated BRAF V600–mutant unresectable or metastatic melanoma: Results from the randomized part 3 of the phase III COMBI-i trial
2020
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
and 1 more

Author Peers

Author Surgery Molecular Biology EDM Oncology Epidemiology Last Decade Papers Cites
T Haas 669 1320 305 2294 2201 72 4.9k
Jie Hou 27 20 27 28 39 231
Nabil Channouf 1 2 2 3 9 289
M. Wik 5 11 337
Akira Kabumoto 14 2 9 474
Bart Streumer 24 340

All Works

Loading papers...

Rankless by CCL
2026